Physician profile
Marc Bosem
NPI 1013951839
$20,125.71
in general payments reported to CMS, 2019-2025
34 companies · $5,084 in 2025
The $5,084 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,225 · 2020: $566 · 2021: $1,475 · 2022: $3,041 · 2023: $2,760 · 2024: $3,974 · 2025: $5,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,440 · Consulting Fee: $4,900 · Travel and Lodging: $1,411 · Gift: $36.07 · Honoraria: $25.59 · Education: $5.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,439.61 |
| Consulting Fee | $4,900.00 |
| Travel and Lodging | $1,411.47 |
| Gift | $36.07 |
| Honoraria | $25.59 |
| Education | $5.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $6,888.36 | 2022-2025 | Teneo, Stellaris Elite, Envista Mx60 Iol |
| Alcon Vision LLC | $3,894.24 | 2019-2025 | Lensx, Wavelight Ex500 Excimer Laser, Rocklatan |
| Carl Zeiss Meditec USA, INC. | $2,311.35 | 2021-2025 | Artevo 800, Visumax |
| Carl Zeiss Meditec, INC. | $1,274.05 | 2019-2024 | Artevo 800, Lumera 700, Veracity Surgical |
| Merz North America, INC. | $1,210.43 | 2019-2022 | |
| Abbvie INC. | $773.96 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Rxsight INC | $620.68 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Allergan, INC. | $350.37 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $348.55 | 2019-2022 | |
| New World Medical,INC. | $253.71 | 2023-2025 | Ahmed Glaucoma Valve, Clearpath, Streamline |
| Glaukos Corporation | $221.41 | 2024 | Idose, Radius |
| Kala Pharmaceuticals, INC. | $200.03 | 2019-2021 | |
| Topcon Healthcare, INC. | $189.70 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $185.30 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $176.90 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $153.97 | 2019 | |
| Horizon Therapeutics Plc | $146.46 | 2021 | |
| Shire North American Group INC | $102.72 | 2019 | |
| Biotissue Holdings INC. | $101.58 | 2019-2025 | |
| Optos, INC. | $98.92 | 2020 | |
| Novartis Pharmaceuticals Corporation | $86.08 | 2019-2023 | |
| Johnson & Johnson Vision Care, INC. | $83.85 | 2023 | Acuvue |
| Coopervision INC. | $78.24 | 2022 | |
| Lensar, INC. | $59.64 | 2022-2024 | Lensar Laser System |
| Mallinckrodt Hospital Products INC. | $48.83 | 2021-2024 | Acthar |
| Amgen INC. | $47.07 | 2025 | Tepezza |
| Harrow Eye, LLC | $43.58 | 2024-2025 | Iheezo |
| Visionix USA, INC | $41.67 | 2022 | |
| Dompe US, INC. | $29.62 | 2024 | Oxervate |
| Rayner Intraocular Lenses Limited | $25.48 | 2025 | Omidria |
| Tarsus Pharmaceuticals, INC. | $25.00 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $20.33 | 2019 | |
| Staar Surgical Company | $19.05 | 2019 | |
| Baudax Bio INC. | $14.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Bosem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.